like us

Current Clinical Study Categories:

Ulcerative Colitis

Our Philosophy:

Current Clinical Trials

Available Trials? What are the symptoms?

Crohn's Disease

"To raise new questions, new possibilities, to regard old problems from a new angle, requires creative imagination and marks real advance in science.” ~ Albert Einstein

Welcome to the Center for Digestive and Liver Diseases, Inc trials list. Browse the list below to search for clinical research projects.

If you have any comments or suggestions, please contact us.

Available Trials? What are the symptoms?

Inflammatory Bowel Disease (IBD)

Available Trials? What are the symptoms?

Internal Hemorrhoid

Liver Cirrhosis

Available Trials? What are the symptoms?

Available Trials? What are the symptoms?

Protocol RHB-104-01

A Phase III Randomized, Double Blind, Placeb-Controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severe Active Crohn’s Disease

Inflammatory Bowel Disease (UC or Crohn's)

Protocol SYGMA

This is a study for IBD with patient reported outcome.

Protocol Oceania Trial - 2013-01

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease (OCEANIA). This study aims to determine the performance

Crohn's Disease

Protocol 20110232

AMG 181 in Subjects With Moderate to Severe Crohn's Disease. This is a randomized, double-blind, placebo-controlled, parallel group, multiple dose study to...

Protocol CNTO1275CRD3002

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Protocol C87075

SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry

The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as...

Ulcerative Colitis

Protocol 20110166

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis...

Protocol A3921095

A Study to Evaluate Both the Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis (OCTAVE)...

Protocol HMPL 004-03

A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Protocol A7281009

A Study of PF-00547659 in Patients with Moderate to Severe Ulcerative Colitis (TURANDOT). To determine the dose or doses of PF-00547659 that will be the most effective...

"Treat people the way I want to be treated...with care, concern, compassion, and with expertise.

We spend a lot of time getting to know our patients, to better take care of their gastrointestinal and liver needs."

~ Dr. Glenn Gordon

Liver Cirrhosis

Protocol RNLC2131 

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects with Early Decompensation Liver Cirrhosis.

Protocol M14-115

A Multicenter, Randomized, Double Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regiment in Subjects with Moderately to Severley Active Crohn's Disease and Evidence of Mucosal Ulceration.

Protocol M14-033

A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severly Active Ulcerative Colitis

Gastroparesis 

Gastroparesis 

Available Trials? What are the symptoms?

Gastroparesis

Protocol 0119

A Qualitative, Multicenter Study to Develop a Gastroparesis Rating Scale (GRS) to Assess Patient Symptoms Associated with Diabetic and Idiopathic Gastroparesis.

Protocol METO-IN-003 

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women with Symptoms Associated with Diabetic Gastroparesis.

Protocol METO-IN-004

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men with Symptoms Associated with Diabetic Gastroparesis.

Protocol GA28950

A Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors.